Clinical Trials Browser

Phase 1 × Solid Tumor Cancer × trametinib × Clear all

NCT06962254 2025-05-08

Imatinib and Trametinib for KRAS-mutated Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor Cancer